---
title: "BMO Capital Sticks to Their Buy Rating for Merck & Company (MRK)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296482637.md"
description: "BMO Capital analyst Evan Seigerman reiterated a Buy rating on Merck & Company (MRK) with a $170 price target. While UBS’s Michael Yee also issued a Buy rating today, RBC Capital downgraded MRK to Hold."
datetime: "2026-08-20T11:17:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296482637.md)
  - [en](https://longbridge.com/en/news/296482637.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296482637.md)
generator: "portal-rs"
---

# BMO Capital Sticks to Their Buy Rating for Merck & Company (MRK)

BMO Capital analyst Evan Seigerman reiterated a Buy rating on Merck & Company today and set a price target of $170.00.

### Summer Sale - Claim 70% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Seigerman covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Novo Nordisk, and Incyte. According to TipRanks, Seigerman has an average return of 12.7% and a 61.49% success rate on recommended stocks. 

In addition to BMO Capital, Merck & Company also received a Buy from UBS’s Michael Yee in a report issued today. However, on the same day, RBC Capital downgraded Merck & Company (NYSE: MRK) to a Hold.

### Related Stocks

- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [INCY.US](https://longbridge.com/en/quote/INCY.US.md)

## Related News & Research

- [Merck & Co Inc Stock (MRK) Moved Up by 3.41% on Aug 21: Facts Behind the Movement](https://longbridge.com/en/news/296629292.md)
- [Moderna surges on trial win for cancer shot; William Blair upgrades](https://longbridge.com/en/news/296370751.md)
- [Denison Mines (DNN) Receives a Buy from Roth MKM](https://longbridge.com/en/news/296056406.md)
- [BMO Capital Keeps Their Buy Rating on JB Hunt (JBHT)](https://longbridge.com/en/news/296348584.md)
- [Stifel Nicolaus Sticks to Its Buy Rating for Alimentation Couche-Tard Inc (ATD)](https://longbridge.com/en/news/296505976.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**